{
  "id": "f98ac7bb-54f9-49a8-a48e-f42639d11261",
  "answer": "ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has a not yet measurable company news read. Its latest completed weekly trend is negative.",
  "status": "insufficient",
  "as_of": "2026-08-15T09:15:26.105031+00:00",
  "period_end": "2026-08-14",
  "scope": "company and instrument",
  "subject": {
    "type": "ticker",
    "key": "HKG:1541",
    "name": "ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541)",
    "identity": {
      "sharemaestro_id": "d7b397b1-e10e-48b6-a830-5be320750895",
      "canonical_name": "ImmuneOnco Biopharmaceuticals (Shanghai) Inc.",
      "isin": null,
      "lei": null,
      "cik": null,
      "website": null,
      "aliases": [
        "1541"
      ],
      "provider_symbols": {
        "eodhd": [
          "1541.HK"
        ],
        "yahoo": "1541.HK",
        "market": "HKG",
        "alpha_vantage": null
      },
      "same_as": []
    }
  },
  "coverage": {
    "country": "Hong Kong",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "score": 50.0,
  "confidence": 0,
  "evidence_count": 5,
  "independent_sources": 0,
  "freshest_evidence": "2026-08-14T09:43:54+00:00",
  "previous_read": 50.0,
  "change": 0.0,
  "method_version": "public-evidence-1",
  "facts": {
    "sector": "Healthcare",
    "ticker": "1541",
    "company": "ImmuneOnco Biopharmaceuticals (Shanghai) Inc.",
    "country": "Hong Kong",
    "currency": "HKD",
    "exchange": "HKG",
    "industry": "Biotechnology",
    "week_end": "2026-08-14",
    "asset_type": "equity",
    "news_count": 5,
    "trend_state": "negative",
    "latest_close": "3.900000",
    "score_change": 0.0,
    "weekly_change": 23.81,
    "evidence_status": "insufficient",
    "sentiment_score": 50
  },
  "canonical_url": "https://sharemaestro.com/evidence/f98ac7bb-54f9-49a8-a48e-f42639d11261/",
  "evidence_urls": [
    {
      "label": "Company chart",
      "url": "https://sharemaestro.com/terminal/d7b397b1-e10e-48b6-a830-5be320750895/"
    },
    {
      "label": "Company news sentiment",
      "url": "https://sharemaestro.com/sentiment/d7b397b1-e10e-48b6-a830-5be320750895/"
    },
    {
      "label": "Current financial news",
      "url": "https://sharemaestro.com/newsreel/search/?ticker=1541"
    }
  ],
  "limitations": "This is dated market research. Coverage may be delayed, incomplete or unavailable.",
  "record_hash": "aed0c98ee2afc0430afe95a54354af5e25c5fe2fab8a53e1b5f3c202e6920f04",
  "citation": "Sharemaestro, ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541), 2026-08-15, https://sharemaestro.com/evidence/f98ac7bb-54f9-49a8-a48e-f42639d11261/"
}